Select a Region North America


Erion Lipo



Launch Readiness, Market Research

Erion is an Associate at EVERSANA MANAGEMENT CONSULTING, with a background in microbiology research, genetics, and molecular biology. Erion has leveraged his foundational academic knowledge to perform market research, develop pipeline prioritization strategies, and conduct competitive intelligence on behalf of medical device and pharmaceutical companies.

In his doctoral thesis at Tufts University, Erion focused on integrating transcriptomics with proteomics to reveal mechanisms of translation during pathogenic infection, which resulted in two peer-reviewed publications. Prior to this role, Erion was a Research Technician at Tufts University, where he developed viral and non-viral gene therapies for ocular diseases, which resulted in three peer-reviewed publications. Erion earned his bachelor’s degree in psychology from Boston University.

Articles by Erion Lipo

Social Determinants of Health – What Pharma Can Do!

The US Department of Health and Human Services defines Social Determinants of Health (SDoH) as conditions in the places where people live, learn, work, and play that affect a wide range of health risks and outcomes.1 They can be grouped into five major categories: economic stability, education access and quality, healthcare access and quality, neighborhood and built environment, and social and community context. SDoH are considered to be the root causes of health disparities across segments of the population. According to GoInVo, 68% of the impact on health comes from SDoH factors versus other factors such as genetics and medical care.2 Population health – an interdisciplinary, customizable approach that allows […]

Interested in scheduling a meeting or speaking event?


  • このフィールドは入力チェック用です。変更しないでください。